Identification of a predictive model for therapeutic guidance in diffuse large B-cell lymphoma by means of systems pathology
To confirm the association between MYC translocation and patient’s survival. To combine the results obtained by BCL6 and MYC mplex immunofluorescence and FISH in multivariate analysis in order to identify a robust phenotype associated with DLBCL patient’s outcome and overall survival. Multiplexed Immunofluorescence study of new markers involved in tumor progression and treatment resistance
Drs. Elías Campo y Lluís Colomo, Fundació Clínic per a la Recerca Biomèdica, Hospital Clínic.
ACC1Ó-FEDER; La Caixa
Valera et al, Haematologica, 2013
P7304PC00-PCT/EP2012/067815
